STZ
44
-3
XRX
38
-3
CCL
65
3
XOM
44
-4
LMT
55
-4
O
31
-8
PSX
35
-4
PSA
46
-2
DGX
33
-3
D
45
-3
MPC
36
-3
AAL
53
2
MRK
60
2
PM
47
-2
CMG
61
3
CINF
66
2
UA
33
7
OXY
38
-2
DVN
42
-2
AMP
66
-3
STZ
44
-3
XRX
38
-3
CCL
65
3
XOM
44
-4
LMT
55
-4
O
31
-8
PSX
35
-4
PSA
46
-2
DGX
33
-3
D
45
-3
MPC
36
-3
AAL
53
2
MRK
60
2
PM
47
-2
CMG
61
3
CINF
66
2
UA
33
7
OXY
38
-2
DVN
42
-2
AMP
66
-3
Financhill
Back

EPAM Systems, Inc. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Sell
36

EPAM
EPAM Systems, Inc.

Last Price:
$209.18
Seasonality Move:
-0.13%
Sell
18

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$33.50
Seasonality Move:
-0.96%
Sell
36
EPAM Systems, Inc. (EPAM) is a Sell

Is EPAM Systems, Inc. a Buy, Sell or Hold?

  • The current EPAM Systems, Inc. [EPAM] share price is $207.02. The Score for EPAM is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • EPAM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $32.84. The Score for RARE is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

EPAM Stock Price Chart

What is EPAM Systems, Inc.'s stock price today?

  • The EPAM Systems, Inc. share price today is $207.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EPAM is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $32.84
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

EPAM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.2 Buy
Relative Strength Index (14 RSI): 68.3 Buy
Chaikin Money Flow: 506542 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (181.91 - 206.83) Buy
Bollinger Bands (100): (149.62 - 186.4) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.67 Buy
Relative Strength Index (14 RSI): 41.45 Sell
Chaikin Money Flow: -1089594 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.6 - 35.94) Sell
Bollinger Bands (100): (29.09 - 34.15) Buy

EPAM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 208.72 Sell
20-day SMA: 198.11 Buy
50-day SMA: 176.5 Buy
200-day SMA: 169.42 Buy
8-day EMA: 206.29 Buy
20-day EMA: 198.75 Buy
50-day EMA: 184.16 Buy
200-day EMA: 179.39 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.17 Sell
20-day SMA: 34.68 Sell
50-day SMA: 33.7 Sell
200-day SMA: 33.61 Sell
8-day EMA: 13.04 Buy
20-day EMA: 5.99 Buy
50-day EMA: 2.54 Buy
200-day EMA: 0.65 Buy

EPAM Systems, Inc. Earnings Growth & EPAM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $1.02 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

EPAM Systems, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):